Qiagen NV [QGEN] stock is trading at $48.3, up 1.79%. An important factor to consider is whether the stock is rising or falling in short-term value. The QGEN shares have gain 0.71% over the last week, with a monthly amount glided 2.53%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Qiagen NV [NYSE: QGEN] stock has seen the most recent analyst activity on June 24, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $55. Previously, Redburn Atlantic downgraded its rating to Neutral on April 04, 2025. On February 19, 2025, downgrade downgraded it’s rating to Neutral and revised its price target to $42 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight but stick to its price target of $48 on January 06, 2025. Jefferies upgraded its rating to a Buy and raised its price target to $54 on December 10, 2024. HSBC Securities downgraded its rating to Hold for this stock on October 17, 2024, but kept the price target unchanged to $49. In a note dated June 27, 2024, Wolfe Research upgraded an Outperform rating on this stock but restated the target price of $50.
Qiagen NV [QGEN] stock has fluctuated between $37.63 and $48.90 over the past year. Currently, Wall Street analysts expect the stock to reach $51.89 within the next 12 months. Qiagen NV [NYSE: QGEN] shares were valued at $48.3 at the most recent close of the market. An investor can expect a potential return of 7.43% based on the average QGEN price forecast.
Analyzing the QGEN fundamentals
Qiagen NV [NYSE:QGEN] reported sales of 2.00B for the trailing twelve months, which represents a growth of 5.37%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.41.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 47.88 points at the first support level, and at 47.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 48.56, and for the 2nd resistance point, it is at 48.81.
Ratios To Look Out For
For context, Qiagen NV’s Current Ratio is 3.37. On the other hand, the Quick Ratio is 2.83, and the Cash Ratio is 1.24. Considering the valuation of this stock, the price to sales ratio is 5.22, the price to book ratio is 3.07 and price to earnings (TTM) ratio is 115.72.
Transactions by insiders
Recent insider trading involved Sackers Roland, Officer, that happened on Sep 11 ’24 when 25000.0 shares were purchased.
